A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 04 Mar 2016
At a glance
- Drugs Mecobalamin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 29 Feb 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.
- 29 Feb 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 26 Dec 2014 Planned End Date changed from 1 Feb 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov record.